Results 151 to 160 of about 73,761 (306)

Opportunities and Challenges of Population Pharmacogenomics

Annals of Human Genetics, EarlyView.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou, Yoomi Park, Mahamadou D. Camara, Volker M. Lauschke   +3 more
wiley   +1 more source

INTERACTION BETWEEN TACROLIMUS AND CHLORAMPHENICOL IN A RENAL TRANSPLANT RECIPIENT

, 1998
Seth L. Schulman, Leslie M. Shaw, Kathy Jabs, Mary B. Leonard, Kenneth L. Brayman   +4 more
openalex   +1 more source

Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up [PDF]

, 1999
Mark L. Jordan, Ron Shapiro, Carlos Vivas, Velma P. Scantlebury, J McCauley, John McMichael, Parmjeet Randhawa, A J Demetris, John J. Fung, Thomas E. Starzl   +9 more
openalex   +1 more source

CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study

Allergy, EarlyView.
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini, Marcus Maurer, Yevgeniya Dytyatkovska, Ewa Springer, Maria Ratkova, Borislava Krusheva, Chun Wook Park, Grazyna Pulka, Marta Chełmińska, Adam Reich, Sunghyun Kim, Keumyoung Ahn, Suyoung Kim, Sewon Lee, Jieun Ka, Jongho Kim, Clive Grattan   +16 more
wiley   +1 more source

ORAL TACROLIMUS TREATMENT OF SEVERE COLITIS IN CHILDREN: LONG-TERM FOLLOWUP

, 1998
Athos Bousvaros, Barbara S. Kirschner, Steven L. Werlin, Lorraine Parker-Hartigan, F Daum, Katherine Freeman, J P Balint, Ross S. Kendall, Alice S. Day, A M Griffiths, George Ferry, Alan M. Leichtner   +11 more
openalex   +1 more source

Optimizing Tacrolimus Dosing During Hospitalization After Kidney Transplantation: A Comparative Model Analysis. [PDF]

Ann Transplant
Mok S, Park SC, Yun SS, Park YJ, Sin D, Hyun JK.   +5 more
europepmc   +1 more source

Tacrolimus Ointment does not Affect Collagen Synthesis: Results of a Single-Center Randomized Trial

, 1998
Sakari Reitamo, Jonna Rissanen, Anita Remitz, Håkan Granlund, Pekka Erkko, Pekka Autio, Antti I. Lauerma, Peter Elg   +7 more
openalex   +1 more source

Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials [PDF]

, 1999
Greg Knoll, Richard Bell
openalex   +1 more source

Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system

Andrology, EarlyView.
Abstract Background Growing evidence indicates that paternal condition significantly influences pregnancy outcomes and offspring health. However, assessing the safety of paternal drug exposure via randomized controlled trials poses ethical challenges, and relevant clinical studies consume a lot of resources to evaluate only a few drugs.
Yanbin Zeng, Wanlong Lin, Wei Zhuang
wiley   +1 more source

Robust UPLC-MS/MS Method With Acetonitrile for Precise Intracellular Quantification of Tacrolimus in PBMCs: A Step Toward Clinical Integration. [PDF]

Clin Transl Sci
Tanathitiphuwarat N, Leelahavanichkul A, Chariyavilaskul P, Udomkarnjananun S.   +3 more
europepmc   +1 more source